Ovid Therapeutics is a biotechnology firm that focuses on developing therapies to treat neurological disorders.
Business Model:
Revenue: $216.8M
Employees: 11-50
Address: 1460 Broadway
City: New York
State: NY
Zip: 10036
Country: US
Ovid Therapeutics is a biotechnology firm that focuses on developing therapies to treat neurological disorders.
Contact Phone:
+16466617661
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
5/8/2017
IPO Valuation:
$369M
Ticker Symbol:
OVID
IPO Price:
$15/share
Amount Raised:
$75M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2015 | Series B | 8 | $75M |
Sphera Funds Management Jennison Associates Redmile Group Tekla Capital Management Fidelity Management and Research Company DoubleLine Equity Healthcare Fund Sanofi Ventures Cormorant Asset Management Fidelity Management and Research Company Sphera Funds Management Jennison Associates Redmile Group Tekla Capital Management Fidelity Management and Research Company DoubleLine Equity Healthcare Fund Sanofi Ventures Cormorant Asset Management Fidelity Management and Research Company |
3/2015 | Venture Round | $5.1M | 1/2017 | Series C | $25.9M | 2/2019 | Post-IPO Equity | $28.2M | 10/2014 | Equity | $5.1M | 8/2015 | Series B | $75M |
Sanofi-Genzyme BioVentures Tekla Capital Management LLC Sphera Funds Management Jennison Associates, LLC Redmile Group |
5/2017 | IPO | $75M | 8/2020 | Debt | $50M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|